ACRS - Aclaris Therapeutics announces patent license agreement with Sun Pharma for alopecia
2023-12-05 16:05:02 ET
More on Aclaris Therapeutics
- Stocks To Watch: Nvidia, Lowe's, Deere And Best Buy Line Up To Report
- Aclaris Therapeutics: The Many Lives Of This Biopharmaceutical Developer
- Aclaris plummets as mid-stage trial for arthritis therapy fails
- Seeking Alpha’s Quant Rating on Aclaris Therapeutics
- Historical earnings data for Aclaris Therapeutics
For further details see:
Aclaris Therapeutics announces patent license agreement with Sun Pharma for alopecia